How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis
11/02/2016
/
Publications
/
Chemotherapy
PT101
Published in the Green Journal, this ESTRO-HERO (Health Economics in Radiation Oncology) analysis reported about 4 millions new cancer patients are predicted in...
Establishing evidence-based indications for proton therapy.
10/11/2016
/
Publications
/
Clinical Trial
PT101
An overview of current clinical trials of proton therapy published in the Red Journal. A total 122 ongoing trials with target enrolment of over 42,000 patients...
Long-term outcomes of proton therapy for previously untreated hepatocellular carcinoma (HCC).
10/03/2017
/
Publications
The Japanese group in University of Tsukuba conducted this retrospective study of 129 patients with stage 0 to C disease (BCLC) treated with proton therapy.
...
Long-term outcome of a prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer.
01/01/2017
/
Publications
This MD Anderson study published in the Green Journal reported proton therapy for early stage NSCLC patients who were not suitable for SBRT due to lesion size...
PRONTOX – a randomized control trial.
10/11/2016
/
Publications
/
Chemotherapy
Although radiochemotherapy with photons is the standard treatment for now for locally advanced NSCLC, but acute radiation-induced toxicity such as esophagitis...
Patterns of care in proton therapy for children.
01/09/2016
/
Publications
Published in the Red Journal, this paper examined patterns of treatments received for pediatric patients with primary CNS malignancies.
The authors pointed out...
Cost effectiveness
01/02/2016
/
Publications
/
PT101
A systematic review of the cost-effectiveness of proton therapy found that proton therapy was a cost-effective option for several pediatric brain tumors...
National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer
25/06/2021
/
Publications
/
Model-based approach
Model-based approach
In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of...
NTCP Models for Severe Radiation Induced Dermatitis After IMRT or PT for Thoracic Cancer Patients.
04/03/2020
/
Publications
/
IMRT
In order to analyze the incidence of acute radiation induced dermatitis (RD) and develop normal tissue complication probability (NTCP) models for severe RD in...
The FRPT 2021 Conference brings together the latest radiation therapies of today with the research and trials that are shaping the oncology treatment of...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.